Resveratrol Protects Against Doxorubicin-induced Cardiomyopathy Through Modulation Of SIRT1/p300/NF-kB In Aged Mice

被引：0
|
作者：
Sin, Thomas K. [1 ]
Yung, Benjamin Y. [1 ]
Yip, Shea-ping [1 ]
Ying, Michael [1 ]
Rudd, John A. [2 ]
Siu, Parco M. [1 ]
机构：
[1] Hong Kong Polytech Univ, Kowloon, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Sha Tin, Hong Kong, Peoples R China
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2014年 / 46卷 / 05期
关键词：
D O I：
10.1249/01.mss.0000495456.86265.e7
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
2450
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [1] Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein
    Kuno, Atsushi
    Hori, Yusuke S.
    Hosoda, Ryusuke
    Tanno, Masaya
    Miura, Tetsuji
    Shimamoto, Kazuaki
    Horio, Yoshiyuki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (08) : 5963 - 5972
  • [2] β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice
    Sanajou, Davoud
    Ahmad, Saeed Nazari Soltan
    Hosseini, Vahid
    Kalantary-Charvadeh, Ashkan
    Marandi, Yasser
    Roshangar, Leila
    Bahrambeigi, Saman
    Mesgari-Abbasi, Mehran
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (05) : 633 - 640
  • [3] Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis
    Sin, Thomas K.
    Tam, Bjorn T.
    Yung, Benjamin Y.
    Yip, Shea P.
    Chan, Lawrence W.
    Wong, Cesar S.
    Ying, Michael
    Rudd, John A.
    Siu, Parco M.
    JOURNAL OF PHYSIOLOGY-LONDON, 2015, 593 (08): : 1887 - 1899
  • [4] β-lapachone protects against doxorubicin-induced hepatotoxicity through modulation of NAD+/SIRT-1/FXR/p-AMPK/NF-kB and Nrf2 signaling axis
    Kalantary-Charvadeh, Ashkan
    Ahmad, Saeed Nazari Soltan
    Aslani, Somayeh
    Beyrami, Mehdi
    Mesgari-Abbasi, Mehran
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)
  • [5] Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity
    Lee, J.
    Connelly, K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [6] Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity
    Lee, J.
    Connelly, K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [7] Pyrroloquinoline quinone protects against doxorubicin-induced cardiotoxicity in mice by modulating Nrf2 and NF-kB activities
    Wang, Hechao
    Li, Junchao
    SCIENCEASIA, 2024, 50 (04):
  • [8] Resveratrol, a SIRT1 activator, prevents cardiomyopathy in dystrophin-deficient mice by down-regulation of p300
    Kuno, A.
    Tanno, M.
    Miki, T.
    Ishikawa, S.
    Horio, Y.
    Miura, T.
    EUROPEAN HEART JOURNAL, 2012, 33 : 803 - 803
  • [9] Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
    Liu, Yan
    Asnani, Aarti
    Zou, Lin
    Bentley, Victoria L.
    Yu, Min
    Wang, You
    Dellaire, Graham
    Sarkar, Kumar S.
    Dai, Matthew
    Chen, Howard H.
    Sosnovik, David E.
    Shin, Jordan T.
    Haber, Daniel A.
    Berman, Jason N.
    Chao, Wei
    Peterson, Randall T.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (266)
  • [10] Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway
    Kalantary-Charvadeh, Ashkan
    Sanajou, Davoud
    Hemmati-Dinarvand, Mohsen
    Marandi, Yasser
    Khojastehfard, Mehran
    Hajipour, Hamed
    Mesgari-Abbasi, Mehran
    Roshangar, Leila
    Ahmad, Saeed Nazari Soltan
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (04) : 297 - 305
12345